Duchenne Muscular Dystrophy (DMD) Treatment Includes Physiotherapy, Medication, Surgery And Regular Monitoring Of Metabolic And Cardiac Function

Duchenne Muscular Dystrophy (DMD) Treatment
Duchenne Muscular Dystrophy (DMD) Treatment

Duchenne muscular dystrophy is a common genetic disease and it is characterized by progressive muscle weakness. The disease leads to premature death. It affects males more often than females. Duchenne is caused by a mutation in the dystrophin gene, which is located on the X chromosome. A mutation in the dystrophin gene is rare, and occurs in less than one in 5,000 babies.

There is no cure for Duchenne Muscular Dystrophy (DMD) Treatment currently, whereas it can be delayed with certain medications. The disease is caused by a gene mutation that results in loss of dystrophin protein production in the muscles. Dystrophin is important in maintaining the strength and flexibility of muscle cells. It helps to stabilize the plasma membrane of muscle fibers, which in turn keeps muscle cells from breaking down.

Symptoms of DMD may spread to other parts of the body and they can begin in the hips and thighs. These symptoms can progress to the arms and shoulders, and the disease may affect the heart. Duchenne Muscular Dystrophy (DMD) Treatment includes medication, physiotherapy, and regular monitoring of metabolic and cardiac function. If symptoms do not respond to medication, surgery may be considered. Surgery can help to relieve muscle tension and correct scoliosis.

The Duchenne Muscular Dystrophy (DMD) Treatment Market is expanding as a result of increasing investments in research and development to find an effective DMD treatment.

There are also newer treatments that can help people with DMD live longer and more active lives. These treatments include the use of stem cells to replace muscle cells. Some researchers are also researching ways to turn stem cells into muscle cells. These therapies are still in the early stages of development, as there are some promising ideas on the horizon.

Another Duchenne Muscular Dystrophy (DMD) Treatment is the use of a medication called eteplirsen. The medication promotes the production of dystrophin. It has been studied in preclinical trials and clinical trials. However, there have been some concerns about the efficacy of eteplirsen. The medication is available in tablet form.

Children suffering with DMD can also receive physical and occupational therapy. Occupational therapists help children develop a daily exercise plan to help them maintain muscle function. Physical therapists can also assist children with breathing problems and other health complications. Pfizer Inc., declared that they are initiating the Phase 3 study for evaluating fordadistrogene movaparvovec, the investigational mini-dystrophin gene therapy in three sites in the U.S., in April 2022.

Comments

Popular posts from this blog

Vehicle-To-Vehicle (V2V) Communication; Used To Wirelessly Interchange Data Regarding Their Speed, Place, And Heading

Global Ferrous Sulfate Market Is Anticipated To Witness High Growth Due To Growing Demand In The Water Treatment Segment And Increasing Applications In Cement And Agriculture

Global Polyphenol Market Is Expanding Owing To Growing Development Of Polyphenol-Rich Products For Health Improvement